|
Recognizing Innovative
Organizations that are Dramatically Reducing
the Cost of Quality Healthcare |
|
|
Congratulations to the 2010
Leadership in Innovation and
ABBY Award Winners |
 |
|
ABBY Winners
proudly display their Awards: Jim
Knape, CEO of VQ OrthoCare, for
"Innovation in Med/Bio-Technology"
(top left), Joe Peterson, MD, CEO of
Specialists On Call, for "Innovative
Approach for the Delivery of
Healthcare" (top right), Debra
Reisenthel, Founding CEO, Novasys
Medical, for "Leadership in
Innovation," and Jaye Connolly,
President of A-Life Medical, for
"Innovation in Healthcare
Information & Telecommunications
Technology" (bottom right).
Awards Event "Pre-Noter" Dave Sayen,
Regional Administrator of CMS, (top
middle) and Mimi Grant, President of
ABL.
|
 |
Debra has led
Novasys Medical, a women’s health
company, since its inception, in
2001. Along the way, she
raised $90 million in venture
capital to see the company’s
flagship product, the Renessa®
System, through product development,
animal studies, human clinical
trials, FDA-approval, market
acceptance, and widespread
reimbursement. In a market
with huge challenges, few
visionaries remain a company’s chief
executive throughout the entire
progression, from idea to
commercialization.
|
|
 |
Dave Sa˙en,
Region IX Administrator for Centers for
Medicare & Medicaid Services, has
long been a proponent of innovative CMS
"Demonstration Programs" designed to improve
the quality of accessible healthcare for our
nation's most vulnerable: Medicare
beneficiaries, as well as the poor, aged,
blind and disabled assisted through Medicaid
- all while saving taxpayers money. He'll
detail for us some of the programs he's most
excited about.
|
|
|
|
 |
L to R
Dan Michel, Founder & CEO of Dakim,
ABBY Award Winner for Innovative
Approach
Faiz Kayyem, Ph.D., CEO of Osmetech
Molecular Diagnostics, ABBY Award
Winner for Medical/Bio-Technology
Jeff Tangney, Co-Founder, President
and COO of Epocrotes, ABBY Award
Winner for Healthcare IT and Telecom |
| |
|
 |
|
|
Patrick Soon-Shiong
is truly a gift to 21st
Century Healthcare. Immigrating to
America with only a med school degree from
South Africa’s University of the Witwatersrand, Patrick joined the faculty of UCLA
in 1983, where he performed the
first islet-cell transplant.
The named inventor on over 50 issued
U.S. patents, Patrick has published 100+
scientific papers, and since leaving
UCLA in 1991, he’s also founded two
publicly traded pharmaceutical
companies, Abraxis Bioscience, which
brought to market Abraxane - the
world’s first nanotechnology
cancer-fighting drug, and American
Pharma Partners, which he sold last
year to Fresenius for $3.7 billion.
Read More
|
|
|
|
 |
L to R
Medical/Bio/Technology
Euan
Thomson,
Ph.D.
CEO of
Accuray,
Inc.
Approach
Wright L.
Lassiter,
III
CEO of
Alameda
County
Medical
Center
IT & Telcomm
Michael
Finke
CEO of
M*Modal,
Inc.
Mimi Grant,
President of
ABL
Organization
|
|
|
|
|
|
|
|
|
|
|
|
